Noted: Mark Craven, a professor of Biostatistics and Medical Informatics at the University of Wisconsin-Madison, has used the previous iteration of Poon’s work for research on genes potentially related to breast cancers that are resistant to the most common types of treatments, called triple-negative breast cancer.
Office of Strategic Communication